Brightsurf Science News & Current Events

February 27, 2004
Breakthrough cancer treatment Avastin receives first approval in the US
Roche today announced that Genentech has received approval from the US Food and Drug Administration (FDA) for Avastin (bevacizumab, rhuMAb-VEGF), an innovative new cancer drug, to be used with intravenous 5-Fluorouracil-based chemotherapy as treatment for patients with previously untreated metastatic cancer of the colon or rectum (first-line treatment).

Ice sheets caused massive sea level change during late Cretaceous
Scientists using cores drilled from the New Jersey coastal plain have found that ice sheets likely caused massive sea level change during the Late Cretaceous Period -an interval previously thought to be ice-free.

The Academy of Electronic Media earns NSF grant and engineering award for multimedia courseware
The Academy of Electronic Media at Rensselaer Polytechnic Institute has received double recognition for pioneering innovative multimedia courseware to help undergraduate college students grasp the basic concepts of engineering systems, from cars to computers chips, to complex music synthesizers.

American Thoracic Society Journal news tips for March 2004 (first issue)
Newsworthy journal highlights include studies showing that: investigators have challenged the premise that tuberculosis (TB) generally results from a single strain of Mycobacterium tuberculosis by demonstrating that multiple infections are present; researchers have published the first report of culturing airborne M. tuberculosis aerosols generated from the coughs of TB patients; and the growing interest in gastric bypass surgery shows the serious challenges faced by physicians in treating the morbidly obese.

The fastest stopwatch in the world
German-Austrian research team presents a method of measuring time in the region of a few hundred attoseconds, allowing the observation of atomic processes on this time scale.

Breakthrough mine-detection turns ocean floor 'transparent'
Since 1776, when naval mines were invented, navies have rightfully feared the stealthy and relatively simple weapons, which can disable or destroy warships and paralyze vital shipping.

Workshop for new synchrotron light source at Brookhaven
The first national users meeting for NSLS-II, a new synchrotron light source, will be held at Brookhaven Lab.

Louisiana Tech students research, showcase alum's exercise invention
Students at Louisiana Tech get an opportunity to research and showcase a new exercise invention brought to Tech for development by an alumnus.

Drugs limit deadly side effects of graft-versus-host disease
A new class of anti-cancer drugs, currently being tested in human clinical trials, reduces the severity of graft-versus-host disease or GVHD -- a common and often deadly complication of life-saving bone marrow transplants -- without suppressing the immune response required to kill lingering cancer cells.

Using soils as filters to prevent 'crypto' from moving to the groundwater
Pathogen-contaminated groundwater has been the cause of many disease outbreaks and was the subject of a recent study published in Vadose Zone Journal.

Rosetta launch delayed for technical reasons
Today's launch of Flight 158 with the Rosetta spacecraft will be delayed by a few days to allow for a minor repair to the external thermal protection on Ariane 5's core cryogenic stage.

UW study: Baby's face lights up emotional center of new mom's brain
When a new mom gazes at her baby, it's not just her mood that lights up - it's also a brain region associated with emotion processing, according to a new study from the University of Wisconsin-Madison.

New ORNL complex wins award for green construction
Building a is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to